P16 and P53 Play Distinct Roles in Different Subtypes of Breast Cancer: e76408

Breast cancers are heterogeneous and complex diseases, and subtypes of breast cancers may involve unique molecular mechanisms. The p16INK4a and p53 pathways are two of the major pathways involved in control of the cell cycle. They also play key roles in tumorigenesis. However, whether the roles of t...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2013-10, Vol.8 (10)
Main Authors: Shan, Ming, Zhang, Xianyu, Liu, Xiaolong, Qin, Yu, Liu, Tong, Liu, Yang, Wang, Ji, Zhong, Zhenbin, Zhang, Youxue, Geng, Jingshu
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Breast cancers are heterogeneous and complex diseases, and subtypes of breast cancers may involve unique molecular mechanisms. The p16INK4a and p53 pathways are two of the major pathways involved in control of the cell cycle. They also play key roles in tumorigenesis. However, whether the roles of these pathways differ in the subtypes of breast cancer is unclear. Therefore, p16 and p53 expression were investigated in different breast cancer subtypes to ascertain their contributions to these cancers. A total of 400 cases of non-invasive ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC), including the major molecular subtypes luminal-A, luminal-B, Her-2, and triple-negative subtypes, and 50 cases of normal controls were compared. Luminal-A cancers expressed the lowest level of p16 among the subtypes in DCIS, and the level of p16 expression was up-regulated in the luminal-A of IDC (P
ISSN:1932-6203
DOI:10.1371/journal.pone.0076408